Cited by 72Chemokine receptors and signalingProtease and Inhibitor MechanismsConnective Tissue Growth Factor Research

Chemokine-protease interactions in cancer

Van Damme, Jo, Struyf, Sofie, Opdenakker, Ghislain·2004·Seminars in Cancer Biology

Abstract

Solid tumour and leukemic cells expressing chemokine receptors, metastasize to chemokine-secreting organs. Chemokines indirectly affect tumour development by attracting immunocompetent cells with pro- or anti-tumoral activities. Various membrane-associated and soluble proteases selectively cleave specific chemokines. Precursor plasma chemokines (CXCL7, CCL14) need to be proteolytically processed to obtain receptor affinity. Angiogenic CXC chemokines (CXCL1, CXCL8) have increased CXCR1/CXCR2 affinity after limited NH2-terminal processing, whereas truncated angiostatic chemokines (CXCL10) show lower CXCR3 affinity without loss of angiostatic potential. NH2-terminally cleaved monocyte chemotactic proteins (CCL2, CCL7, CCL8) have impaired capacity to attract tumour-associated macrophages and function as receptor antagonists for intact CC chemokines. Migration of Th1/CCR5+ and Th2/CCR4+ effector lymphocytes toward CCR5 (CCL5, CCL3L1) and CCR4 (CCL22) ligands is affected by cleavage. Although proteolytical processing of chemokines is well studied in vitro, the direct or indirect effects on tumour invasion and metastasis are only poorly evaluated.

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2003.10.007

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-8 is important in inflammatory diseases such as psoriasis, Crohn's disease, and cancer.

    “The importance of IL-8 has made this chemokine important in inflammatory diseases such as psoriasis, Crohn’s disease, and cancer (80, 81).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Van Damme, J., Struyf, S., & Opdenakker, G.
Affiliations
Rega Institute for Medical Research (BE)
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2004-06
Volume
14
Issue
3
Pages
201-208
ISSN
1044-579X (ISSN-L)
OpenAlex
W2056407781
Cited by
71
References
82
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 2
FWCI
3.37
Type
journal article
Language
en
Open access
closed
Locations
  • Seminars in Cancer Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
Keywords
tumour metastasis, tumour-associated macrophages, CXCR3, CCR5, CCR4, CCL22, RANTES, CXCL10, angiogenesis, tumor invasion, CXCL7, CCL14, interleukin-8
MeSH terms
Humans, Neoplasms, Peptide Hydrolases, Chemokines, CXC

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review